Page last updated: 2024-11-05

zolpidem and Hyperphagia

zolpidem has been researched along with Hyperphagia in 2 studies

Zolpidem: An imidazopyridine derivative and short-acting GABA-A receptor agonist that is used for the treatment of INSOMNIA.
zolpidem : An imidazo[1,2-a]pyridine compound having a 4-tolyl group at the 2-position, an N,N-dimethylcarbamoylmethyl group at the 3-position and a methyl substituent at the 6-position.

Hyperphagia: Ingestion of a greater than optimal quantity of food.

Research Excerpts

ExcerptRelevanceReference
"Zolpidem is an imidazopyridine which binds to certain benzodiazepine receptor types with varying degrees of affinity."5.32Evidence for zolpidem-induced hyperphagia, but not anxiolysis, in a successive negative contrast paradigm. ( Flaherty, CF; Mitchell, CP; Ost, ML, 2004)
"Zolpidem is an imidazopyridine which binds to certain benzodiazepine receptor types with varying degrees of affinity."1.32Evidence for zolpidem-induced hyperphagia, but not anxiolysis, in a successive negative contrast paradigm. ( Flaherty, CF; Mitchell, CP; Ost, ML, 2004)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Allison, KC1
Tarves, EP1
Mitchell, CP1
Ost, ML1
Flaherty, CF1

Other Studies

2 other studies available for zolpidem and Hyperphagia

ArticleYear
Treatment of night eating syndrome.
    The Psychiatric clinics of North America, 2011, Volume: 34, Issue:4

    Topics: Anorexia; Behavior Therapy; Circadian Rhythm; Cognitive Behavioral Therapy; Depression; Diet Records

2011
Evidence for zolpidem-induced hyperphagia, but not anxiolysis, in a successive negative contrast paradigm.
    Pharmacology, biochemistry, and behavior, 2004, Volume: 79, Issue:3

    Topics: Animals; Anxiety; Dose-Response Relationship, Drug; Hyperphagia; Male; Pyridines; Rats; Rats, Spragu

2004